Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.

Biomarkers in cancer Pub Date : 2017-05-17 eCollection Date: 2017-01-01 DOI:10.1177/1179299X17710016
L S F Boogerd, F A Vuijk, C E S Hoogstins, H J M Handgraaf, M J M van der Valk, P J K Kuppen, C F M Sier, C J H van de Velde, J Burggraaf, A Fariña-Sarasqueta, Alexander L Vahrmeijer
{"title":"Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.","authors":"L S F Boogerd,&nbsp;F A Vuijk,&nbsp;C E S Hoogstins,&nbsp;H J M Handgraaf,&nbsp;M J M van der Valk,&nbsp;P J K Kuppen,&nbsp;C F M Sier,&nbsp;C J H van de Velde,&nbsp;J Burggraaf,&nbsp;A Fariña-Sarasqueta,&nbsp;Alexander L Vahrmeijer","doi":"10.1177/1179299X17710016","DOIUrl":null,"url":null,"abstract":"<p><p>Carcinoembryonic antigen (CEA)-targeted imaging and therapeutic agents are being tested in clinical trials. If CEA overexpression in malignant tissue corresponds with elevated serum CEA, serum CEA could assist in selecting patients who may benefit from CEA-targeted agents. This study aims to assess the relationship between serum CEA and CEA expression in pancreatic (n = 20) and rectal cancer tissues (n = 35) using histopathology. According to local laboratory standards, a serum CEA >3 ng/mL was considered elevated. In pancreatic cancer patients a significant correlation between serum CEA and percentage of CEA-expressing tumor cells was observed (<i>P</i> = .04, ρ = .47). All 6 patients with homogeneous CEA expression in the tumor had a serum CEA >3 ng/mL. Most rectal cancer tissues (32/35) showed homogeneous CEA expression, independent of serum CEA levels. This study suggests that selection of pancreatic cancer patients for CEA-targeted agents via serum CEA appears adequate. For selection of rectal cancer patients, serum CEA levels are not informative.</p>","PeriodicalId":72377,"journal":{"name":"Biomarkers in cancer","volume":" ","pages":"1179299X17710016"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179299X17710016","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers in cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1179299X17710016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

Abstract

Carcinoembryonic antigen (CEA)-targeted imaging and therapeutic agents are being tested in clinical trials. If CEA overexpression in malignant tissue corresponds with elevated serum CEA, serum CEA could assist in selecting patients who may benefit from CEA-targeted agents. This study aims to assess the relationship between serum CEA and CEA expression in pancreatic (n = 20) and rectal cancer tissues (n = 35) using histopathology. According to local laboratory standards, a serum CEA >3 ng/mL was considered elevated. In pancreatic cancer patients a significant correlation between serum CEA and percentage of CEA-expressing tumor cells was observed (P = .04, ρ = .47). All 6 patients with homogeneous CEA expression in the tumor had a serum CEA >3 ng/mL. Most rectal cancer tissues (32/35) showed homogeneous CEA expression, independent of serum CEA levels. This study suggests that selection of pancreatic cancer patients for CEA-targeted agents via serum CEA appears adequate. For selection of rectal cancer patients, serum CEA levels are not informative.

Abstract Image

Abstract Image

Abstract Image

术前血清癌胚抗原水平与胰腺癌和直肠癌组织表达的相关性
癌胚抗原(CEA)靶向显像和治疗剂正在临床试验中进行测试。如果恶性组织中CEA过表达与血清CEA升高相对应,血清CEA可以帮助选择可能受益于CEA靶向药物的患者。本研究旨在通过组织病理学评估血清CEA与胰腺癌(n = 20)和直肠癌组织(n = 35)中CEA表达的关系。根据当地实验室标准,血清CEA >3 ng/mL为升高。在胰腺癌患者中,血清CEA与表达CEA的肿瘤细胞百分比有显著相关性(P = 0.04, ρ = 0.47)。肿瘤中CEA均表达的6例患者血清CEA均>3 ng/mL。大多数直肠癌组织(32/35)CEA表达均匀,与血清CEA水平无关。本研究表明,通过血清CEA选择胰腺癌患者的CEA靶向药物似乎是足够的。对于直肠癌患者的选择,血清CEA水平并不能提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信